Skip to content
★ Sign in to follow
Interojo Inc. logo

Interojo Inc. Stock: price and insider trades · South Korea

인터로조

KR·Mcap ₩181.7BHealth Care

No insider purchase over the last 90 days. The latest, by 김용직, was filed 20 Jul 2026.

Interojo Inc.: what insiders have been doing

Interojo Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 10 November 2026, brought 6 filings signed by 2 insiders.

The flow runs one way only: 2 insiders bought (6 purchases) and nobody sold on the market. No amount is published for 6 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 board members.

Across the 2,630 companies tracked on its exchange, the median is 7 filings; at 6 filings, this issuer sits below that mark. Over the whole record (from 2021), the tally stands at 46 purchases and 3 sales.

The most recent open-market purchase was published on 28 July 2026, 105 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
52
Thresholds
n/a
Buy Volume
n/a
46 ops. · all time
Sell Volume
n/a
3 ops. · all time

Who traded when

BuySale
김용직4 buys
안희준2 buys
국민연금공단1 sale
노시철1 buy
Fundamental score
Ranked 2,698 of 26,911 companies
74.1
score / 100
Value
82
Quality
66
FCF yld13%
Earn yld8.8%
EV/EBITDA6.2x
ROE11%
Gross mgn35%
Net mgn11%
Debt/EBITDA0.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩15,920
Analyst consensus
1 analysts
·
₩21,000Target ₩21,000(+32%)₩21,000
Income statement
Revenue₩118.4B
Gross profit₩42B35% margin
EBITDA₩28B24% margin
Net income₩12.9B14.3% margin
Valuation
PER (forward)6.2x
Beta0.40
Balance sheet & cash
Market cap₩181.7B
Total debt₩25.9B
Free Cash Flow₩18.4B
Debt / Equity36%
Profitability & ownership
ROE11.3%
ROA6.1%
% insiders37.9%
% institutions9.7%
Last declaration on 20 July 2026
Declarations53 total
  • Other
    Other(filed)
    0DART
  • ▲
    감사Executives(filed)
    0DART
    1,900 sharesShareKRXDART:20260720000054
    Canonical exit: 18 Oct 2026 (T+90)
  • ▲
    Executives
    0DART
    4,000 sharesShareKRXDART:20260626000427
    Canonical exit: 22 Sept 2026 (T+90)
  • ▲
    Executives
    0DART
    2,000 sharesShareKRXDART:20260615000072
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20260605000257
    Canonical exit: 3 Sept 2026 (T+90)
  • ▲
    Executives
    0DART
    700 sharesShareKRXDART:20260520000018
    Canonical exit: 16 Aug 2026 (T+90)
  • ●
    Executives
    Executives
    0DART
  • ▲
    Executives
    0DART
    300 sharesShareKRXDART:20250806000117
    Canonical exit: 30 Oct 2025 (T+90)
  • ▲
    대량보유자Executives
    0DART
    300 sharesKRXDART:20250806000119
    Canonical exit: 28 Oct 2025 (T+90)
  • ▼
    대량보유자Executives
    0DART
    312,201 sharesKRXDART:20250702000138
  • ●
    Executives
    0DART
    0KRXDART:20240920000354
  • ▼
    Executives
    0DART
    204,676 sharesKRXDART:20240702000334
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20240605000420
    Canonical exit: 27 Aug 2024 (T+90)
  • ▲
    전무Executives
    0DART
    ShareKRXDART:20240604000206
    Canonical exit: 4 Jul 2024 (T+90)
  • ▲
    전무Executives
    0DART
    ShareKRXDART:20240508000470
    Canonical exit: 28 Apr 2024 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20240507000421
    Canonical exit: 4 Jul 2024 (T+90)
  • ▲
    대량보유자Executives
    0DART
    522,434 sharesKRXDART:20240503000027
    Canonical exit: 2 Jul 2024 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20231010000538
    Canonical exit: 4 Jan 2024 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20231005000286
    Canonical exit: 22 Oct 2023 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20230901000311
    Canonical exit: 20 Nov 2023 (T+90)
  • ▲
    전무Executives
    0DART
    ShareKRXDART:20230720000323
    Canonical exit: 2 Oct 2023 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20230710000118
    Canonical exit: 11 Sept 2023 (T+90)
  • ▲
    전무Executives
    0DART
    ShareKRXDART:20230706000420
    Canonical exit: 2 Jul 2023 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20230704000299
    Canonical exit: 13 Aug 2023 (T+90)
  • ▲
    Executives
    0DART
    277 sharesKRXDART:20230704000407
    Canonical exit: 26 Sept 2023 (T+90)

25 of 53 declarations

About Interojo Inc.

인터로조 is a company operating in the health and pharmaceutical sector, listed on the XKRX. It specializes in the development and distribution of pharmaceutical products.